Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Silverio

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Journal of Chemotherapy (Florence, Italy)|August 1, 1994
Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycinF Chiarini, A Mansi, P Tomao, et al.
Journal of Andrology|March 1, 1996
Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunctionV Gentile, A Modesti, G La Pera, et al.
European Urology|January 1, 1997
Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasiaG Martorana, C Giberti, F Di Silverio, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptorsC Lubrano, F Sciarra, G Spera, et al.
Journal of Steroid Biochemistry|January 1, 1989
Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasiaC Lubrano, E Petrangeli, A Catizone, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1993
Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasiaC Lubrano, V Toscano, E Petrangeli, et al.
Journal of Andrology|July 20, 2000
Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaPL Ravenna, L Salvatori, S Morrone, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 19, 2000
Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levelsA Sciarra, G D'Eramo, P Casale, et al.
The Prostate|October 6, 1998
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaF Di Silverio, S Monti, A Sciarra, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgensS Monti, F Di Silverio, R Iraci, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Journal of Chemotherapy (Florence, Italy)|August 1, 1994
Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycinF Chiarini, A Mansi, P Tomao, et al.
Journal of Andrology|March 1, 1996
Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunctionV Gentile, A Modesti, G La Pera, et al.
European Urology|January 1, 1997
Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasiaG Martorana, C Giberti, F Di Silverio, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptorsC Lubrano, F Sciarra, G Spera, et al.
Journal of Steroid Biochemistry|January 1, 1989
Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasiaC Lubrano, E Petrangeli, A Catizone, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1993
Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasiaC Lubrano, V Toscano, E Petrangeli, et al.
Journal of Andrology|July 20, 2000
Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaPL Ravenna, L Salvatori, S Morrone, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 19, 2000
Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levelsA Sciarra, G D'Eramo, P Casale, et al.
The Prostate|October 6, 1998
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaF Di Silverio, S Monti, A Sciarra, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgensS Monti, F Di Silverio, R Iraci, et al.
Pageof 15